Aradhana Sarin
2019
In 2019, Aradhana Sarin earned a total compensation of $4.9M as Executive Vice President, Chief Financial Officer at Alexion Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $813,011 |
|---|---|
| Salary | $651,764 |
| Stock Awards | $3,380,763 |
| Other | $31,604 |
| Total | $4,877,142 |
Sarin received $3.4M in stock awards, accounting for 69% of the total pay in 2019.
Sarin also received $813K in non-equity incentive plan, $651.8K in salary and $31.6K in other compensation.
Rankings
In 2019, Aradhana Sarin's compensation ranked 2,287th out of 13,971 executives tracked by ExecPay. In other words, Sarin earned more than 83.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,287 out of 13,971 | 84th |
Division Manufacturing | 825 out of 5,701 | 86th |
Major group Chemicals And Allied Products | 262 out of 2,200 | 88th |
Industry group Drugs | 211 out of 1,886 | 89th |
Industry Pharmaceutical Preparations | 154 out of 1,398 | 89th |
Source: SEC filing on March 26, 2020.
Sarin's colleagues
We found five more compensation records of executives who worked with Aradhana Sarin at Alexion Pharmaceuticals in 2019.
2019
Ludwig Hantson
Alexion Pharmaceuticals
Chief Executive Officer
2019
Paul Clancy
Alexion Pharmaceuticals
Chief Financial Officer
2019
John Orloff
Alexion Pharmaceuticals
Executive Vice President, Head of Research and Development
2019
Brian Goff
Alexion Pharmaceuticals
Executive Vice President, Chief Commercial and Global Operations Officer
2019
Anne-Marie Law
Alexion Pharmaceuticals